vialaudit
SEMAX·PENNSYLVANIA·LAST CHECKED 1 NOV 2026

Is Semax legal in Pennsylvania?

CAVEATS APPLY

We found no Pennsylvania statute, board rule or enforcement action that names Semax, so federal law applies. Not as a drug. Semax has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. It is approved in Russia, which has no effect in the US. Under an interim HHS policy of 28 October 2026, a licensed pharmacy may compound it against a prescription, by set routes and under strict conditions, without federal enforcement. That policy does not cover research-use-only vials sold online.

CATEGORY · NO APPROVAL

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: pcac recommended
HHS interim policy (Oct 28, 2026): no enforcement against licensed 503A compounding with a prescription · routes: intranasal only (free base) · FEDERAL REGISTER ↗
Still not on the 503A Bulks List and not an approved drug. Removed from Category 2 on 15 Apr 2026. On 24 Jul 2026 the PCAC recommended it for the Bulks List. On 28 Oct 2026 HHS issued an interim 'Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances' (Federal Register 30 Oct 2026, 91 FR 68526). HHS says it does not intend to take enforcement action against a state-licensed pharmacy, Federal facility or licensed physician compounding Semax against a patient-specific prescription, limited to intranasal only, as a single ingredient, from API made by an FDA-registered facility with a full certificate of analysis. The Federal Register notice calls the policy a draft that is not binding; comments close 13 Nov 2026 (docket HHS-OASH-2026-0496). It does not cover 503B outsourcing facilities or research-use-only vials sold online.
PCAC review history
  • Jul 24, 2026 · recommended · 8 yes, 5 no, 1 abstention (law-firm reports) · SOURCE ↗
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies. PCAC pending — current status is unapproved with formal review pathway opening.
Personal possession: Not federally criminalized.

Pennsylvania — state-specific

Sport-body status

WADA 2026
not prohibited
Not named. Semax is approved in Russia, so S0 does not apply on its text. Check with your anti-doping organisation.
USADA
not banned
NCAA
unknown

What we couldn’t verify

Also known as

3 ALIASES

Semax is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Russian Semax
  • ACTH analogue (4-10)
  • Methionyl-Glutamyl-Histidyl-Phenylalanyl-Prolyl-Glycyl-Proline

Related

FOLLOW-ONS

Semax: US status, sources and what changed

Other states with a rule that names Semax: Indiana. Everywhere else, federal law applies.

THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH